Peter Grayson, MD, MSc, and Raashid Luqmani, MBBS, DM, FRCP, provided an overview of the new ACR/EULAR classification criteria for vasculitis, the ACR’s first update to the classification criteria for vasculitis since 1990.

Of the six late-breaking abstracts presented at ACR Convergence 2021, three highlighted the importance of COVID-19 vaccination and booster shots for immunocompromised patients.

Investigators presented findings from six significant studies, including the JUNIPERA trial, during Plenary III on Monday, Nov. 8.

Yasmine Belkaid, PhD, Renuka Nayak, MD, PhD, and Jose U. Scher, MD, discussed a growing body of research designed to harness the microbiota communities that live on our exposed surfaces, from the gut to the skin and eyes.

Dan Kastner, MD, PhD, described the unique, genotype-first strategy that researchers used to identify and define VEXAS syndrome, a complex rheumatic disease that had not been defined by conventional research approaches.

Kenneth G. Saag, MD, MSc, became the 85th ACR President on Tuesday, Nov. 9, at the annual ACR Business Meeting. The Board of Directors was also confirmed.

Beginning December 10, the ACR Convergence virtual platform will be updated nearly every Friday with additional live learning opportunities.